Page tree
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 72 Next »


Objective

CodeX (the Common Oncology Data Elements eXtensions) is an HL7 FHIR Accelerator, building a community to accelerate interoperable data modeling and applications based on a common language for cancer data.  The language is mCODE, the minimal Common Oncology Data Elements, often with extensions developed in CodeX for the new, critical use cases. 

Adoption of an mCODE-based common language for cancer will lead to incremental improvements in cancer care and research, benefiting all cancer patients. 

For background, see the more detailed overview. Subscribe to the general mailing Listserv below to keep up to date on CodeX.


Use Cases

A number of potential CodeX Use Cases are now in the Discovery phase. These are Use Cases that promise to substantially improve cancer care and research through community alignment around the use of mCODE and necessary extensions for sharing of standard, structured cancer data.  Current and prospective CodeX members are reviewing and building out Use Cases that will become the first CodeX projects. We are also launching the mCODE Community of Practice to share best practices for basic mCODE implementation within EHRs for routine data collection and sharing.  Contact Steve Bratt or Greg Shemancik to join the conversation.

Membership

Welcome to our Founding Members!  We are talking with tens of organizations interested in joining CodeX. Our Founding Member list will be released shortly.  Contact Steve Bratt or Greg Shemancik to discuss membership.

Operations

Building a community to accelerate a common language for cancer data requires specialized, quality support. As the CodeX initiative rolls out, we will document the roles and responsibilities for CodeX Program/Project Management, the Steering Committee, the Operating Committee, and how we'll maintain architectural Integrity and accelerate capabilities by training and sharing across the community. Check back in February.

Products

As CodeX Use Cases are prioritized and new projects are started, FHIR Implementation Guides, Best Practices and other projects will be linked here.  Stay tuned.

Site Contents


Since last October’s Cancer Data Summit, we’ve made substantial progress in our goal to enable interoperability across cancer patient data and systems. Using mCODE™ to collect, share, and extract data from EHRs means that every interaction between a clinician and cancer patient provides data that could be used to improve care for all future patients.
MITRE and the  HL7® FHIR® Accelerator CodeX Community https://confluence.hl7.org/display/COD/CodeX+Home invite you to a unique MITRE Listening Session on oncology clinical pathways and prior authorization of cancer therapies on June 26, 2020 from 10:00-11:30 EDT.  Oncology is a dynamic specialty with a rapid expansion of new therapies and tumor genomics.  Over the past five years the use of oncology clinical pathways became a standard approach to assist oncologists in treatment recommendations.…
Thanks to presenters Dr. Lawrence Shulman, Dr. Peter Gabriel of UPenn, Melanie Combs-Dyer - Director of Innovation at Mettle Solutions and Tyler Haydell - Senior Product Manager at Flatiron Health. The slides and a recording of the meeting can be found here. Please join the July 31, 2020 CodeX mCODE Community of Practice meeting on July 31, 2020, noon, where we will discuss the CodeX Oncology Clinical Pathways: Prior Authorization use case. We hope to see you there!

Team:

Position: CodeX Lead

Position: Deputy CodeX Lead

Position: Technical Lead

Position: Deputy CodeX Tech Lead

Position: Scrum Master




  • No labels